David has a clinical background in Pharmacy, graduating from the University of Bradford in 2012 with a MPharm (Hons). David is currently studying a PhD at the University of Bradford, funded by the NIHR Yorkshire and Humber Patient Safety Translational Research Centre, under the Safe Use of Medicines, and Digital Innovations research themes.
Prior to beginning his PhD, David worked full-time as a Practice Pharmacist in General Practice, responsible for the safe and effective use of medicines in the management of both acute and long-term conditions. David served a predominantly elderly population, and developed an interest in safer prescribing in the care of the elderly. He maintains a clinical day once a week to ensure his research remains relevant and can be translated into clinical practice. He has also previously worked within the Greater Manchester Patient Safety Translational Research Centre, contributing to the Patient Safety Collaborative initiative.
A new career in patient safety…thanks to the Community Pharmacy Patient Safety Collaborative!
David is completing a PhD which focuses on high-risk prescribing in older people living with frailty. It is well established that certain high-risk medicines are associated with adverse health outcomes in the elderly, such as physical dysfunction, falls, cognitive dysfunction, institutionalisation and even death. However, this is not well established in older people living with frailty, with very limited research worldwide. Frailty has emerged as a very important aspect of geriatric medicine, recognised as a state of vulnerability to poor resolution of homoeostasis after a stressor event and is a consequence of cumulative decline in many physiological systems. Minor stressor events may trigger disproportionate changes in health status, therefore David’s research will explore the associations with adverse outcomes when exposed to high-risk prescribing in frailty, and explore whether frailty modifies these associations. More specifically, anticholinergic medicines with antimuscarinic properties will be explored, as there is international consensus that these medicines should ideally be avoided in the elderly. David will use a mixed-methods approach in his PhD, with a sequential explanatory design. Methods such as systematic literature reviewing, quantitative analysis of prospective cohort data and routinely collected electronic health records, and qualitative interviews with clinicians will be incorporated.
David has a general research interest in the quality and safety of prescribing. He is interested in how innovative technological approaches can be used to make prescribing safer and reduce patient harm. The development of clinical decision support tools to support clinicians and patients in decision making with regards to medicines is at the forefront of his research.